Besides, several targets such as CA2, HMOX1, GSTA1, and NOS2 were closely associated with anemia (Lin et al., 2013), which could exhibit significant influences on the therapeutic effects of XSHG. The gene discussed is NOS2; the disease is anemia (phenotype).